Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT05263024

Study on the Significance of Auricular Clip in Prevention and Treatment of Valvular Heart Disease Atrial Thrombosis

To evaluate the safety and clinical efficacy of left atrial appendage in the prevention of thrombus in patients with valvular heart disease, to improve the product according to clinical conditions, to achieve clinically accurate treatment, and to establish the heart valve, the usefulness and universality of Warfarin's anticoagulant model were verified by the specimen library

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Atrial fibrillation (AF) is a common arrhythmia. The risk of ischemic stroke in AF patients is 4-5 times higher than that in non-af patients, and leads to nearly 20% mortality and nearly 60% disability. Atrial fibrillation is associated with valvular disease and atrial fibrillation in about 30-70% of patients with valvular heart disease. Left atrial thrombus occurs in 15-25% of patients with atrial fibrillation. More than 90% of patients with atrial thrombus is located in the left atrial appendage. In patients with valvular atrial fibrillation, the left atrial appendage is clamped at the same time of valvular surgery to avoid recurrence of atrial thrombus-related stroke. In this clinical trial, the left atrial appendage was used to clamp the prethrombotic site of the heart to prevent stroke and improve the prognosis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with valvular heart disease aged between 18 and 75
  • Valvular heart disease [Cardiovascular Surgery Volume, Clinical Diagnosis and Treatment Guidelines, Chinese Medical Association (2011 edition)]
  • Preoperative cardiac function grade II-III (NYHA), no operation-related contraindications
  • Understand the nature of this study, agree to participate in all terms of this study, sign informed consent, agree to accept postoperative treatment plan and follow-up requirements, and cooperate to complete follow-up

Exclusion criteria

  • Patients whose left atrial appendage has been resected or occluded
  • She had a history of open heart surgery with extensive adhesion of the pericardium
  • Patients cannot be returned due to other reasons
  • Failed to reach the end point in clinical trials of other drugs or devices
  • X-ray is contraindicated or not suitable for TEE examination
  • Those who are considered unsuitable for the clinical trial by the investigator

Treatment and study plan

atrial appendage clip

Device

During cardiac surgery, atrial fibrillation patients were treated with atrial appendage clipping

Primary outcomes

  1. Success rate of auricular clip clipping

    Time frame: 12 months

    Success rate of auricular clip clipping

  2. Clinical success rate of auricular clip

    Time frame: 12 months

    Rate of patients without ischemic stroke, TIA, or systemic embolism 12 months after cardiac and auricular clipping

Sponsors and collaborators

Lead sponsor

Second Affiliated Hospital of Nanchang University

Other

Registry information

Official study title

Study on the Significance of Auricular Clip in Prevention and Treatment of Valvular Heart Disease Atrial Thrombosis and the Related Precision Treatment Technique

Important dates

Study start
2022
Primary completion
2025
Study completion
2027
First posted
Mar 2, 2022
Registry last updated
Mar 2, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.